[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606742":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":20,"responsibleParty":32,"collaborators":34,"id":38,"slug":7,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":41,"acronym":42,"eligibilityCriteria":43,"healthyVolunteers":39,"sex":44,"minAge":45,"maxAge":7,"enrollmentInfo":46,"targetDuration":7,"studyType":49,"phases":7,"briefSummary":50,"conditions":51,"keywords":53,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Bioceramed","INDUSTRY",null,[9],{"name":10,"affiliation":11,"role":12},"João Botelho","Egas Moniz School of Health and Science Caparica, Lisboa, Portugal","PRINCIPAL_INVESTIGATOR",[14],{"name":15,"role":16,"phone":17,"phoneExt":18,"email":19},"Alexandre Barros","CONTACT","253 573 460","+351","info@bioceramed.com",[21],{"facility":22,"status":23,"city":24,"state":7,"zip":7,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":7},"Egas Moniz School of Health and Science","RECRUITING","Lisbon","Portugal",{"type":27,"coordinates":28},"Point",[29,30],-9.1498,38.72509,{"lat":30,"lon":29},{"type":33,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[35],{"name":36,"class":37},"Egas Moniz - Cooperativa de Ensino Superior, CRL","OTHER","100606742",false,"NCT07179510","Evaluation of the Safety and Performance of the Neocement® Inject P: A Prospective Observational Study in Dental Area","NeoInjDent01","Inclusion Criteria:\n\n* Adult males or females (age \\> 18 years old);\n* Patients who are able to sign an informed consent form (for data collection);\n* Patients undergoing reconstructive dental surgery and indicated for the use of Neocement® Inject P;\n\nExclusion Criteria:\n\n* Patients who are unable to understand consent and the objectives of the study;\n* Signs of local or systemic acute\u002F active or chronic infections;\n* Metabolic affections;\n* Severe degenerative diseases, conditions in which general bone grafting is not advisable;\n* Implementation sites that allow product migration;\n* Conditions which require structural support in the skeletal system;\n* Conditions where the implantation site is unstable and not rigidly fixated;\n* Sensibility to the implantable materials;\n* Known hypersensitivity to the implant material.","ALL","18 Years",{"count":47,"type":48},66,"ESTIMATED","OBSERVATIONAL","This study aims to collect real-world clinical data to gather information on the performance and safety of the Neocement® Inject P when used according to its intended purpose and current clinical applications. The results of the clinical study will serve as clinical evidence for the device's clinical evaluation.",[52],"Bone Augmentation",[54,55,56,57,58,59,60,61,62,63],"prospective observational clinical study","bone substitute","bone defects","real-world clinical data","safety","performance","medical device","reconstructive dental surgeries","Neocement® Inject P","calcium phosphates","2026-06-17",{"date":66,"type":67},"2026-06-18","ACTUAL",{"date":69,"type":67},"2025-10-06",{"date":71,"type":48},"2027-10",{"name":5,"class":6},1]